A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study-Reference-Cited by-同舟云学术

A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study

Published:2016-05 Issue:3 Volume:17 Page:232-236.e1
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Planchard David,Yokoi Takashi,McCleod Michael J.,Fischer Jürgen R.,Kim Young-Chul,Ballas Marc,Shi Kelvin,Soria Jean-Charles

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference17 articles.

1. The need for third-line treatment in non-small cell lung cancer: an overview of new options;Syrigos;Anticancer Res,2011

2. Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): sensitivity analysis of trials in melanoma, lung and genitourinary cancers;Carbognin;PLoS One,2015

3. Innate and adaptive immune cells in the tumor microenvironment;Gajewski;Nat Immunol,2013

4. Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response;Kvistborg;Sci Transl Med,2014

5. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multi-component paclitaxel −loaded β-elemene nanoemulsion by transferrin modification enhances anti-non-small-cell lung cancer treatment;International Journal of Pharmaceutics;2024-09

2. Advancing non-small cell lung cancer treatment: the power of combination immunotherapies;Frontiers in Immunology;2024-07-02

3. Fertility Preservation in the Era of Immuno-Oncology: Lights and Shadows;Journal of Personalized Medicine;2024-04-19

4. Immunotherapy Efficacy Prediction in Cancer: An Artificial Intelligence Approach with Unannotated H&E Whole-Slide Images;2024-02-07

5. Correlation of preclinical and clinical biomarkers with efficacy and toxicity of cancer immunotherapy;Therapeutic Advances in Medical Oncology;2023-01